triamcinolone has been researched along with incb-018424 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howell, MD; Kim, BS; Kuligowski, ME; Nasir, A; Papp, K; Sun, K | 1 |
| Bieber, T | 1 |
| Kim, BS; Kuligowski, ME; Nasir, A; Papp, K; Sun, K; Venturanza, M | 1 |
2 trial(s) available for triamcinolone and incb-018424
| Article | Year |
|---|---|
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.
Topics: Adult; Anti-Inflammatory Agents; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Skin Cream; Triamcinolone | 2020 |
Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Minimal Clinically Important Difference; Nitriles; Pruritus; Pyrazoles; Pyrimidines; Quality of Life; Severity of Illness Index; Skin Cream; Triamcinolone; Young Adult | 2020 |
1 other study(ies) available for triamcinolone and incb-018424
| Article | Year |
|---|---|
Leveraging the nice face of Janus kinase inhibition-ruxolitinib cream in atopic dermatitis.
Topics: Dermatitis, Atopic; Humans; Janus Kinase 1; Janus Kinase 2; Nitriles; Pyrazoles; Pyrimidines; Triamcinolone | 2020 |